COPD pathophysiology: climbing the waterfall of cell death to find a target
- PMID: 37003614
- DOI: 10.1183/13993003.00093-2023
COPD pathophysiology: climbing the waterfall of cell death to find a target
Conflict of interest statement
Conflicts of interest: D. Cataldo is a founder of Aquilon Pharmaceuticals; he has received speaker fees from AstraZeneca, Boehringer Ingelheim, Chiesi and GSK, and received consultancy fees from Aquilon Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Chiesi, Sanofi and GSK for participation in advisory boards and workgroups.
Comment on
-
RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD.Eur Respir J. 2023 Apr 1;61(4):2201506. doi: 10.1183/13993003.01506-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36549711
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous